TSX:SVA (Sernova Corp.)

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood, and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.